ZMYND11 and breast carcinoma: Our results suggested that USP53 was low expressed in breast cancer and negatively correlated with TNM stage; USP53 suppressed proliferation and triggered apoptosis of breast cancer cells; USP53 inhibited breast cancer in vitro and in vivo by deubiquitinating ZMYND11.